Yesterday was Inauguration Day plus one and apparently the markets are very happy with what they've heard from the new ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback